HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Foraging adds natural flavor to fresh dishes
- China trip leaves India media impressed
- Setting ropes and mapping crevasses, brave summiteer keeps fellow valiants safe
- Success for 'silver-haired' tourism trains
- China's space station delivers new samples for research
- Escape the city, embrace shores and slow living